Please provide your email address to receive an email when new articles are posted on . Combination drugs for treating glaucoma offer obvious advantages in terms of convenience and patient compliance.
Feasibility and safety results from RAD-IO: A multi-stage trial of durvalumab (Medi4736) with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results